LifeGuide Financial Advisors’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$702K Buy
29,545
+2,854
+11% +$68.1K 0.2% 25
2026
Q1
$637K Buy
26,691
+3,106
+13% +$74.8K 0.2% 27
2025
Q4
$571K Buy
23,585
+963
+4% +$23.3K 0.19% 27
2025
Q3
$544K Buy
22,622
+89
+0.4% +$2.14K 0.2% 32
2025
Q2
$541K Buy
22,533
+279
+1% +$6.62K 0.2% 32
2025
Q1
$529K Buy
22,254
+5,586
+34% +$132K 0.22% 27
2024
Q4
$391K Sell
16,668
-795
-5% -$18.9K 0.17% 32
2024
Q3
$421K Buy
17,463
+311
+2% +$7.42K 0.18% 32
2024
Q2
$400K Buy
17,152
+2,019
+13% +$47K 0.19% 31
2024
Q1
$355K Buy
15,133
+688
+5% +$16.2K 0.18% 33
2023
Q4
$341K Buy
14,445
+2,239
+18% +$51.2K 0.18% 37
2023
Q3
$276K Buy
+12,206
New +$280K 0.16% 33

Other funds holding IBD

LifeGuide Financial Advisors's IBD Position: Q2 2026 in Review

LifeGuide Financial Advisors increased its Inspire Corporate Bond ETF (IBD) stake by 11% in Q2 2026, buying an estimated $68.1K and bringing the position to 29,545 shares worth $702K. The position accounts for 0.2% of the portfolio, ranked #25.

LifeGuide Financial Advisors first reported a position in IBD in Q3 2023 and has held it in 12 quarters since. 18 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • LifeGuide Financial Advisors held 29,545 shares of Inspire Corporate Bond ETF worth $702K as of Q2 2026.
  • LifeGuide Financial Advisors bought 2,854 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $68.1K.
  • Inspire Corporate Bond ETF made up 0.2% of LifeGuide Financial Advisors's portfolio in Q2 2026, its #25 holding.
  • LifeGuide Financial Advisors first reported a position in Inspire Corporate Bond ETF in Q3 2023 and has held it in 12 quarters since.
  • 18 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on LifeGuide Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.